Navigation Links
Griffith joins the fight against pneumonia
Date:11/11/2013

Advancing the fight against pneumonia is the focus of a new online scholarly journal launched by Griffith University ePress.

With an aim to establish an international forum on this deadly disease, pneumonia.org.au is a peer-reviewed, open-access journal which brings together knowledge related to its pathogenesis, treatment and prevention.

Griffith's Professor Allan Cripps is the Editor in Chief of pneumonia, which features original research articles, case studies, reviews, critical commentaries, correspondence, highlights and news on all aspects of the disease.

"Pneumonia is the leading cause of death in children worldwide and kills an estimated 1.2 million children under the age of five every year," says Professor Cripps during the lead up to this year's World Pneumonia Day (November 12).

"Relatively few resources have been committed to addressing the problem of childhood pneumonia, particularly in resource-poor settings.

"However we are starting to see some fantastic support from organisations such as the GAVI Alliance which has assisted over 20 countries to introduce the pneumococcal conjugate vaccine which prevents the most common form of childhood pneumonia.

"And we have also seen unprecedented investment by the Bill and Melinda Gates Foundation to support the research, development and delivery of life-saving vaccines for the world's poorest countries.

"Pneumonia is part of this overall pledge to raise the global profile of this forgotten killer and advance the fight against childhood mortality."

As the only scientific journal exclusively focused on the disease, pneumonia is starting to gain some momentum. The journal is now publishing in its second volume and has so far received over 20,000 page visits from every continent across 100 countries."

It has also been chosen as the assigned journal for the 9th International
'/>"/>

Contact: Louise Durack
l.durack@griffith.edu.au
041-964-9516
Griffith University
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Steve Fisher joins American Health IT LLC as VP of Operations
2. Brazil joins international marine research effort
3. Advanced Clinical Joins MedNet Solutions iMedNet Partner Program
4. Brazil joins global initiative for biodiversity data access
5. Book shows evolution that joins human and environmental sciences
6. FASEB joins President Obama in urging Congress to sustain investments in research and innovation
7. Warren Lammert Joins IntelliMedix Board of Advisors
8. Denmark joins the Nordic EMBL Partnership for Molecular Medicine
9. Einstein joins the New York Genome Center as 12th institutional founding member
10. CARE Pharmacies Joins National Association of Specialty Pharmacy (NASP) as a Founding Corporate Member
11. Iris Biometrics Leader EyeLock Joins the FIDO Alliance to Help Identify More Secure Replacement for Usernames and Passwords
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Griffith joins the fight against pneumonia
(Date:7/13/2015)... Jul. 13, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD ... convenient and secure method to make payments.  With ... methods, introduced with its groundbreaking voice-direct payment patent ...
(Date:7/9/2015)... , July 9, 2015  Synaptics Inc. ... of human interface solutions, today announced a ... first fully hardware encapsulated fingerprint sensor and ... technology is literally off the grid, isolating ... matching within the fingerprint sensor to provide ...
(Date:7/8/2015)... The consumer products industry for innovative ... products such as wearables, smart wallets & other smart technology ... devices continues to rapidly grow.  Biometrics & Wearable Device Companies ... Google Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ... (NASDAQ: GPRO ) and Baidu Inc. (NASDAQ: BIDU ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6
... new twist on an old idea, two Clemson University environmental ... cut heating and cooling costs and reduce carbon emissions. ... from the U.S. Department of Defense to create a Subsurface ... a model for energy efficiency. Five military bases are ...
... Cornell University researchers recently stretched individual molecules and ... can be used as powerful new tools for nanoscale ... 11 issue of the journal Science, probes ... important when shrinking electronics to their ultimate small size ...
... In what has been hailed as a breakthrough, scientists ... College have outlined the molecular mechanism of membrane transport. ... to transport substances across the cell membrane in order ... synaptic gap from one neuron to another. Because ...
Cached Biology News:Clemson engineers to create model underground energy-storage facility 2Clemson engineers to create model underground energy-storage facility 3Stretching molecules yields new understanding of electricity 2Helping the brain's messengers get from A to B 2Helping the brain's messengers get from A to B 3
(Date:7/30/2015)... ... 2015 , ... The 2015 Market Research Report on the Global Propanol ... global Propanol market with a focus on the Chinese situation. Major companies included in ... ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The ...
(Date:7/30/2015)... , July 30, 2015   Aratana ... pet therapeutics company focused on the licensing, development ... animals, today announced that its strategic partner VetStem ... dose confirmation study of AT-016, an adipose-derived allogeneic ... the treatment of osteoarthritis pain in dogs. ...
(Date:7/30/2015)... Ascendis Pharma A/S (Nasdaq: ASND ... TransCon technology to address significant unmet medical needs, ... Phase 2 study to evaluate the safety and ... treatment-naïve, pre-pubertal children with growth hormone deficiency, or ... the top-line results from our Phase 2 pediatric ...
(Date:7/30/2015)... ... ... its 2015 growth plan and as a follow up to the recently announced expansion of ... pleased to announce that it has begun construction on a new Microbiological Laboratory. The new ... dedicated to basic USP 51, USP 61, and USP 62 testing specific to raw materials. ...
Breaking Biology Technology:Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2
... , CHICAGO, July 31 ... that it received a complete response letter today from the ... Application (NDA) for Restanza(TM) (cethromycin) for the outpatient treatment of ... letter, the FDA indicated that they cannot approve the application ...
... , , , ... (Nasdaq: CEPH ) announced today that Craig C. Phillips has ... Unit. In this role, Phillips will have responsibility for managing all aspects ... , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090731/PH54744 ...
... Ueno, Ltd. announced on July 29 after discussing its R&D policy ... day and determined the R&D items as follows. , , ... ophthalmologic & dermatological fields that are its priority and exclusive areas, ... 1. Development code UF-021 (eye diseases) , , ...
Cached Biology Technology:Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia 2Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia 3Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia 4Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia 5Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit 2Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit 3Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit 4R-Tech Ueno Notifies R&D Items 2R-Tech Ueno Notifies R&D Items 3
Functionally tested for consistent G-banding of chromosomes....
...
Schneider's Drosophila Medium is formulated for the expression of heterologous proteins in Drosophila S2 cells....
... Andrew J. Davison ... (1993) • Contents include: ... plant viruses, paramyxoviruses, influenza ... also covers analysis of ...
Biology Products: